NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kind Pharmaceuticals

Kind Pharmaceuticals

Private
HangzhouHealthcare & Life Scienceshttp://www.kindpharmaceuticals.com/

Last Round

Series C

Nov 12, 2025

Total Funding Raised

$144M

Company Overview

Kind Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of innovative therapeutics for hematological diseases and cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoverysmall molecule therapeuticsoncologyanemia treatmentantibody-drug conjugatesADCclinical-stage biotechbiotech startuphemoglobin elevating agenthypoxia-inducible factorHIF stabilizationselective estrogen receptor degraderSERDdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kind Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Kind Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kind Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 12, 2025
Series BOct 1, 2021
Series AOct 1, 2019

Kind Pharmaceuticals Investors

Notable investors and investment history

Kind Pharmaceuticals investors
InvestorRounds
Northern Light Venture CapitalSeries C, Series B
Grand InvestmentSeries C
Efung CapitalSeries B, Series C
Decheng CapitalSeries B, Series A
Gaorong CapitalSeries C, Series B
建发新兴投资Series C

Kind Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kind Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kind Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range1
Year Founded2014
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.